MedPath

Short Term Physiological Effects of Nasal High Flow Oxygen on Respiratory Mechanics

Phase 4
Completed
Conditions
Chronic Hypercapnic Respiratory Failure
COPD
Interventions
Device: HOF
Device: noninvasive mechanical ventilation (NIV)
Registration Number
NCT02363920
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

Nasal High Oxygen Flow (HOF) has been demonstrated to reduce the re-intubation rate in hypoxic patients and ameliorate breathing pattern in hypercapnic patients.

The aim of this study is to better understand the physiological mechanism underlying these results, assessing the respiratory mechanics in stable hypercapnic COPD patients.

Detailed Description

Subjects. 10 in-patients with stable COPD and chronic hypercapnic respiratory failure with no history of neurological or chronic cardiac disease will be recruited. They need to be in a phase of clinical stability and were for a short period of rehabilitation. Patients with X-ray evidence of pulmonary edema or congestion and pulmonary infiltrate will be excluded from the study. Written consent will be obtained from all subjects, and the protocol will be approved by the Ethics Committee.

Measurements. Static and dynamic lung volumes assessed by body plethysmography (MasterLab-Jaeger, Hochberg, Germany).

Flow measured with a pneumotachograph (Screenmate Box 0586, Jaeger GmbH, Hochberg, Germany), connected to a rigid mouthpiece.

Airway pressure measured through tubing inserted in the mouthpiece and connected to a differential pressure transducer (Honeywell 300 cm H2O, Freeport, IL, USA). VT obtained by integration of the flow signal. The inspiratory (TI), expiratory (TE) and total breathing cycle (TTOT) duration, respiratory frequency (RR), and duty cycle (TI/TTOT) calculated as average values of 10 consecutive breaths, after 5 minutes of breathing.

Baseline from peak changes in esophageal (Pes), gastric (Pga), and transdiaphragmatic (Pdi) pressures measured using the balloon-catheter technique. Pressure at the airway opening (Paw) measured via a side port.

Respiratory mechanics will be assessed using Mead and Wittenberger's technique. Inspiratory pulmonary resistance (R,L) and elastance (E,L) calculated by fitting the equation of motion of a single-compartment model using multilinear regression.

Dynamic PEEPi (PEEPi,dyn) will be measured according to Appendini et al. The pressure time integrals of the diaphragm and the other inspiratory muscles calculated per breath (PTPdi/b and PTPes/b, respectively) and per minute (PTPdi/min and PTPes/min).

Subjective ratings of dyspnea assessed during the various trials using Borg's scale.

Arterial blood gases (ABGs) measured in samples taken from the radial artery (ABL 550 Radiometer, Copenhagen, Denmark).

The above mentioned variables, excluding arterial blood gases recorded after 15 minutes of spontaneous breathing. At the end of this part of the study, the patients will undergo a randomized 30' trial of: 1) non-invasive mechanical ventilation (NIMV) through a nose mask for 20 minutes while they were in a sitting position. The following pressures will be used: 14 cmH2O of inspiratory aid and 4 cmH2O of expiratory-positive airway pressure. 2) HOF at the flow of 20 L/min 3) HOF at the flow of 30 L/min ECG, SaO2 will be continuosly recorded All signals collected using a personal computer equipped with an A/D board, and stored at a sampling rate of 100 Hz. The mean value of each physiological variable during the 5 minutes of recording used for analyses. Results presented as mean + standard deviation (SD). Differences between physiological parameters recorded in the 3 settings will be analysed by paired Student's T-test. Pearson's coefficient will be used to calculate to assess correlation between variables. A p value \<0.05 chosen as the threshold of statistical significance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria
  • COPD patients
  • Chronic hypercapnic respiratory failure (pH>7.34 and PaCO2>45 mmHg)
Exclusion Criteria
  • Cancer
  • Neurological and cardiac disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
HOF30noninvasive mechanical ventilation (NIV)the patients will be asked to breathe with HOF of 30 L/min
spontaneous breathing trialnoninvasive mechanical ventilation (NIV)the patients will be asked to breathe spontaneously using their acutal low oxygen flow
spontaneous breathing trialHOFthe patients will be asked to breathe spontaneously using their acutal low oxygen flow
noninvasive mechanical ventilation (NIV)HOFthe patients will be asked to breathe with the support of a ventilator via a oro-nasal interface
HOF20noninvasive mechanical ventilation (NIV)the patients will be asked to breathe with HOF of 20 L/min
HOF20HOFthe patients will be asked to breathe with HOF of 20 L/min
HOF30HOFthe patients will be asked to breathe with HOF of 30 L/min
noninvasive mechanical ventilation (NIV)noninvasive mechanical ventilation (NIV)the patients will be asked to breathe with the support of a ventilator via a oro-nasal interface
Primary Outcome Measures
NameTimeMethod
recording of respiratory mechanics30 minutes per arm

Respiratory mechanics will be assessed using Mead and Wittenberger's technique.

Secondary Outcome Measures
NameTimeMethod
dyspnea score30 minutes per arm

dyspnea will be recorded using the Borg scale that is a numeric scale where 0 is no dyspnea and 10 the maximal dyspnea that a patient can imagine

Trial Locations

Locations (1)

San'Orsola Malpighi Hospital, Bologna ITALY

🇮🇹

Bologna, Italy

© Copyright 2025. All Rights Reserved by MedPath